The Emerging Role of Ferroptosis in Liver Diseases
Ferroptosis is a newly discovered type of cell death mediated by iron-dependent lipid peroxide. The disturbance of iron metabolism, imbalance of the amino acid antioxidant system, and lipid peroxide accumulation are considered distinct fingerprints of ferroptosis. The dysregulation of ferroptosis ha...
Saved in:
Published in | Frontiers in cell and developmental biology Vol. 9; p. 801365 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
14.12.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Ferroptosis is a newly discovered type of cell death mediated by iron-dependent lipid peroxide. The disturbance of iron metabolism, imbalance of the amino acid antioxidant system, and lipid peroxide accumulation are considered distinct fingerprints of ferroptosis. The dysregulation of ferroptosis has been intensively studied in recent years due to its participation in various diseases, including cancer, kidney injury, and neurodegenerative diseases. Notably, increasing evidence indicates that ferroptosis plays different roles in a wide spectrum of liver diseases. On the one hand, inhibiting ferroptosis may counteract the pathophysiological progression of several liver diseases, such as alcoholic liver injury, nonalcoholic steatosis hepatitis and fibrosis. On the other hand, inducing ferroptosis may restrict the emergence of secondary resistance to current medicines, such as sorafenib, for hepatocellular carcinoma (HCC) therapy. Here, we summarize the biological characteristics and regulatory signalling pathways of ferroptosis involved in liver disease. The current available medical agents targeting ferroptosis, including inducers or inhibitors applied in liver diseases, are also reviewed. This work aims to provide new insight into the emerging role of pathogenesis and therapeutic approaches for liver diseases. |
---|---|
AbstractList | Ferroptosis is a newly discovered type of cell death mediated by iron-dependent lipid peroxide. The disturbance of iron metabolism, imbalance of the amino acid antioxidant system, and lipid peroxide accumulation are considered distinct fingerprints of ferroptosis. The dysregulation of ferroptosis has been intensively studied in recent years due to its participation in various diseases, including cancer, kidney injury, and neurodegenerative diseases. Notably, increasing evidence indicates that ferroptosis plays different roles in a wide spectrum of liver diseases. On the one hand, inhibiting ferroptosis may counteract the pathophysiological progression of several liver diseases, such as alcoholic liver injury, nonalcoholic steatosis hepatitis and fibrosis. On the other hand, inducing ferroptosis may restrict the emergence of secondary resistance to current medicines, such as sorafenib, for hepatocellular carcinoma (HCC) therapy. Here, we summarize the biological characteristics and regulatory signalling pathways of ferroptosis involved in liver disease. The current available medical agents targeting ferroptosis, including inducers or inhibitors applied in liver diseases, are also reviewed. This work aims to provide new insight into the emerging role of pathogenesis and therapeutic approaches for liver diseases. Ferroptosis is a newly discovered type of cell death mediated by iron-dependent lipid peroxide. The disturbance of iron metabolism, imbalance of the amino acid antioxidant system, and lipid peroxide accumulation are considered distinct fingerprints of ferroptosis. The dysregulation of ferroptosis has been intensively studied in recent years due to its participation in various diseases, including cancer, kidney injury, and neurodegenerative diseases. Notably, increasing evidence indicates that ferroptosis plays different roles in a wide spectrum of liver diseases. On the one hand, inhibiting ferroptosis may counteract the pathophysiological progression of several liver diseases, such as alcoholic liver injury, nonalcoholic steatosis hepatitis and fibrosis. On the other hand, inducing ferroptosis may restrict the emergence of secondary resistance to current medicines, such as sorafenib, for hepatocellular carcinoma (HCC) therapy. Here, we summarize the biological characteristics and regulatory signalling pathways of ferroptosis involved in liver disease. The current available medical agents targeting ferroptosis, including inducers or inhibitors applied in liver diseases, are also reviewed. This work aims to provide new insight into the emerging role of pathogenesis and therapeutic approaches for liver diseases.Ferroptosis is a newly discovered type of cell death mediated by iron-dependent lipid peroxide. The disturbance of iron metabolism, imbalance of the amino acid antioxidant system, and lipid peroxide accumulation are considered distinct fingerprints of ferroptosis. The dysregulation of ferroptosis has been intensively studied in recent years due to its participation in various diseases, including cancer, kidney injury, and neurodegenerative diseases. Notably, increasing evidence indicates that ferroptosis plays different roles in a wide spectrum of liver diseases. On the one hand, inhibiting ferroptosis may counteract the pathophysiological progression of several liver diseases, such as alcoholic liver injury, nonalcoholic steatosis hepatitis and fibrosis. On the other hand, inducing ferroptosis may restrict the emergence of secondary resistance to current medicines, such as sorafenib, for hepatocellular carcinoma (HCC) therapy. Here, we summarize the biological characteristics and regulatory signalling pathways of ferroptosis involved in liver disease. The current available medical agents targeting ferroptosis, including inducers or inhibitors applied in liver diseases, are also reviewed. This work aims to provide new insight into the emerging role of pathogenesis and therapeutic approaches for liver diseases. |
Author | Chen, Si Zang, Xin Zhu, Jun-yao Zhai, Yong-zhen |
AuthorAffiliation | 1 Department of Neurology, The Fourth Affiliated Hospital of China Medical University , Shenyang , China 2 Department of Infectious Disease, Shengjing Hospital of China Medical University , Shenyang , China |
AuthorAffiliation_xml | – name: 2 Department of Infectious Disease, Shengjing Hospital of China Medical University , Shenyang , China – name: 1 Department of Neurology, The Fourth Affiliated Hospital of China Medical University , Shenyang , China |
Author_xml | – sequence: 1 givenname: Si surname: Chen fullname: Chen, Si – sequence: 2 givenname: Jun-yao surname: Zhu fullname: Zhu, Jun-yao – sequence: 3 givenname: Xin surname: Zang fullname: Zang, Xin – sequence: 4 givenname: Yong-zhen surname: Zhai fullname: Zhai, Yong-zhen |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34970553$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kd1LHDEUxUNR6ucf0Jcyj33ZbT5nkhehWK3CgiAKvoWbzM0amZ2syazQ_74zrhYVfMol95zfgXsOyE6feiTkG6NzIbT5GTx23ZxTzuaaMlGrL2Sfc1PPaiHvdt7Me-S4lAdKKeOqUVp8JXtCmoYqJfYJv7nH6myFeRn7ZXWdOqxSqM4x57QeUomlin21iE-Yq9-xIBQsR2Q3QFfw-OU9JLfnZzenF7PF1Z_L01-LmVeCDTMIzqHhbaPANy1K56ljBkLNORqFYARXqI1xQRqoUdEaPCCVelxpoaU4JJdbbpvgwa5zXEH-axNE-_yR8tJCHqLv0IbWBaqc4rXhcjyM0xylZ8E1KrgW6Mg62bLWG7fC1mM_ZOjeQd9v-nhvl-nJ6oYJLs0I-PECyOlxg2Wwq1imBqDHtCmW10wZzhoxSb-_zfof8nr0UdBsBT6nUjIG6-MAQ0xTdOwso3Zq2D43bKeG7bbh0ck-OF_hn3v-AbcpquQ |
CitedBy_id | crossref_primary_10_3389_fcell_2022_881447 crossref_primary_10_11569_wcjd_v33_i1_34 crossref_primary_10_3389_fmed_2024_1356225 crossref_primary_10_3748_wjg_v29_i4_616 crossref_primary_10_1016_j_metabol_2023_155552 crossref_primary_10_1038_s41467_024_46386_6 crossref_primary_10_3390_life12122128 crossref_primary_10_3389_fphar_2024_1464852 crossref_primary_10_1016_j_jpha_2023_11_009 crossref_primary_10_2174_0113894501284110240426074746 crossref_primary_10_1093_lifemedi_lnac035 crossref_primary_10_3390_cells11203301 crossref_primary_10_3390_mi14071368 crossref_primary_10_1016_j_ajpath_2022_08_010 crossref_primary_10_1080_0886022X_2023_2195012 crossref_primary_10_1016_j_ecoenv_2024_116890 crossref_primary_10_1016_j_phrs_2024_107526 crossref_primary_10_1016_j_freeradbiomed_2025_02_045 crossref_primary_10_1016_j_biopha_2023_116074 crossref_primary_10_1016_j_isci_2023_108340 crossref_primary_10_1186_s12906_024_04463_9 crossref_primary_10_3390_cells11132040 crossref_primary_10_1007_s10620_025_08960_w crossref_primary_10_1186_s12935_023_03207_y crossref_primary_10_3389_fphar_2022_851540 crossref_primary_10_3390_immuno2010014 crossref_primary_10_1038_s41388_023_02744_0 crossref_primary_10_3390_cancers14071826 crossref_primary_10_11569_wcjd_v33_i1_28 crossref_primary_10_1016_j_bbadis_2023_166750 crossref_primary_10_1002_lci2_68 crossref_primary_10_1016_j_heliyon_2024_e28865 crossref_primary_10_1038_s41420_022_01199_8 crossref_primary_10_3389_fsurg_2022_878648 crossref_primary_10_2174_0109298673271261231213051410 crossref_primary_10_1007_s00432_024_05878_0 crossref_primary_10_1016_j_cbi_2023_110713 crossref_primary_10_3390_antiox13030352 crossref_primary_10_3389_fonc_2022_852095 crossref_primary_10_3390_ph17070871 crossref_primary_10_1038_s41420_024_01863_1 crossref_primary_10_4251_wjgo_v16_i6_2335 crossref_primary_10_1016_j_heliyon_2024_e35882 crossref_primary_10_1021_acs_jafc_4c04929 |
Cites_doi | 10.1016/j.jphs.2020.07.014 10.21037/atm-21-471 10.3892/ol.2018.8447 10.1016/j.bbi.2021.01.003 10.1038/nchembio.2239 10.1111/liv.14428 10.1111/jcmm.14594 10.1016/j.freeradbiomed.2020.09.008 10.1007/s11684-015-0386-y 10.1371/journal.pone.0170350 10.1016/j.ejphar.2021.174319 10.1016/j.bbrc.2021.02.055 10.1016/j.cell.2012.03.042 10.1093/carcin/bgi222 10.1016/j.jconrel.2021.03.007 10.1016/j.ajpath.2019.09.011 10.1016/s0741-8329(03)00102-2 10.1002/hep4.1333 10.1016/j.redox.2019.101328 10.2147/DMSO.S240786 10.1038/s41598-020-78026-6 10.1016/j.bbrc.2016.08.034 10.1016/j.bbadis.2021.166114 10.3390/ijms22147348 10.1038/s41419-020-2732-5 10.1038/s41419-021-03725-5 10.1016/j.biopha.2018.11.030 10.1002/jcp.29496 10.1016/j.bbrc.2017.07.136 10.1002/jcp.29232 10.1016/j.jconrel.2020.01.008 10.3389/fnagi.2016.00308 10.1038/s41392-020-00428-9 10.3390/ijms21144908 10.1155/2015/269371 10.1042/BSR20200219 10.1038/s41556-018-0178-0 10.1182/blood.2019002907 10.1016/j.redox.2019.101211 10.1080/15548627.2018.1503146 10.1111/febs.16059 10.7150/thno.36283 10.1016/j.ajpath.2019.09.012 10.3748/wjg.v25.i5.521 10.1016/j.bbrc.2021.08.018 10.3390/ijms21249682 10.1007/s12011-021-02627-z 10.1002/hep.28574 10.1155/2019/9437043 10.1155/2020/8810785 10.1002/biof.1797 10.36290/vnl.2020.078 10.1038/s41419-019-1678-y 10.3350/cmh.2020.0142 10.1016/j.cmet.2015.05.002 10.1097/CM9.0000000000000835 10.1016/j.biochi.2020.11.002 10.1038/aps.2017.5 10.1016/j.redox.2020.101619 10.1016/j.freeradbiomed.2019.12.026 10.1080/09168451.2020.1763155 10.1186/s12929-021-00762-2 10.3892/or.2019.7189 10.1073/pnas.1301764110 10.1002/hep.28251 10.1038/s41598-019-52837-8 10.1007/s00018-016-2194-1 10.4143/crt.2016.572 10.1016/j.taap.2019.114665 10.1016/j.bbrc.2016.03.052 10.3390/molecules26041092 10.1038/s41580-020-00324-8 10.4103/0366-6999.202737 10.1016/j.biopha.2018.06.060 10.3390/antiox9121279 10.1016/j.cell.2017.09.021 10.1016/j.ijpharm.2019.118782 10.1097/01.ALC.0000026830.27338.23 10.1007/s11418-021-01491-4 10.3390/ijms22157906 10.1016/j.pathophys.2016.11.002 10.2147/OTT.S254995 10.1038/s41572-020-00240-3 10.1016/j.tox.2020.152599 10.7150/thno.57803 10.1016/j.canlet.2014.11.014 10.1038/s41420-021-00660-4 10.1016/j.cellsig.2020.109633 10.1016/j.cell.2013.12.010 10.1038/s41422-020-00441-1 10.1093/humrep/deaa363 10.1007/978-981-15-7360-6_20 10.1053/j.gastro.2013.11.008 10.1007/s12272-020-01273-8 10.1016/j.chembiol.2021.07.022 10.3390/antiox10071030 10.1016/j.redox.2021.102151 10.1016/j.tox.2020.152584 10.1073/pnas.1607152113 10.1080/15548627.2019.1687985 10.1016/j.tcb.2020.02.009 10.1016/j.freeradbiomed.2020.01.009 10.1007/s00432-018-2740-3 10.19540/j.cnki.cjcmm.20180517.001 10.1051/jbio/2020002 10.1038/s41419-021-03998-w 10.1111/cas.14181 |
ContentType | Journal Article |
Copyright | Copyright © 2021 Chen, Zhu, Zang and Zhai. Copyright © 2021 Chen, Zhu, Zang and Zhai. 2021 Chen, Zhu, Zang and Zhai |
Copyright_xml | – notice: Copyright © 2021 Chen, Zhu, Zang and Zhai. – notice: Copyright © 2021 Chen, Zhu, Zang and Zhai. 2021 Chen, Zhu, Zang and Zhai |
DBID | AAYXX CITATION NPM 7X8 5PM DOA |
DOI | 10.3389/fcell.2021.801365 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | CrossRef PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
DocumentTitleAlternate | Chen et al |
EISSN | 2296-634X |
ExternalDocumentID | oai_doaj_org_article_fdbf05b526924fceb82e4c1fb75fbda0 PMC8713249 34970553 10_3389_fcell_2021_801365 |
Genre | Journal Article Review |
GroupedDBID | 53G 5VS 9T4 AAFWJ AAYXX ACGFS ACXDI ADBBV ADRAZ AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK GROUPED_DOAJ GX1 HYE KQ8 M48 M~E OK1 PGMZT RPM EMOBN IAO IEA IHR IHW IPNFZ ISR NPM RIG 7X8 5PM |
ID | FETCH-LOGICAL-c531t-afbbe92d75ac7de4bc0b19af622e95ea9325e899bf49a6e506acae048ea983843 |
IEDL.DBID | M48 |
ISSN | 2296-634X |
IngestDate | Wed Aug 27 01:20:09 EDT 2025 Thu Aug 21 18:23:24 EDT 2025 Fri Jul 11 11:16:05 EDT 2025 Thu Jan 02 22:55:38 EST 2025 Thu Apr 24 23:12:41 EDT 2025 Tue Jul 01 01:17:00 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | fibrosis liver diseases ferroptosis cell death hepatocellular carcinoma |
Language | English |
License | Copyright © 2021 Chen, Zhu, Zang and Zhai. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c531t-afbbe92d75ac7de4bc0b19af622e95ea9325e899bf49a6e506acae048ea983843 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 Edited by: Hai-Feng Zhang, Sun Yat-sen Memorial Hospital, China This article was submitted to Cell Death and Survival, a section of the journal Frontiers in Cell and Developmental Biology Reviewed by: Yujun Luo, Third Affiliated Hospital of Sun Yat-sen University, China Leibo Xu, Sun Yat-sen University, China |
OpenAccessLink | https://doaj.org/article/fdbf05b526924fceb82e4c1fb75fbda0 |
PMID | 34970553 |
PQID | 2615921739 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_fdbf05b526924fceb82e4c1fb75fbda0 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8713249 proquest_miscellaneous_2615921739 pubmed_primary_34970553 crossref_citationtrail_10_3389_fcell_2021_801365 crossref_primary_10_3389_fcell_2021_801365 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2021-12-14 |
PublicationDateYYYYMMDD | 2021-12-14 |
PublicationDate_xml | – month: 12 year: 2021 text: 2021-12-14 day: 14 |
PublicationDecade | 2020 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland |
PublicationTitle | Frontiers in cell and developmental biology |
PublicationTitleAlternate | Front Cell Dev Biol |
PublicationYear | 2021 |
Publisher | Frontiers Media S.A |
Publisher_xml | – name: Frontiers Media S.A |
References | Park (B49) 2019; 379 Yu (B90) 2019; 42 Zhang (B96) 2019; 24 Sang (B57) 2019; 9 Doll (B12) 2017; 13 Zhang (B99); 16 Yu (B93) 2020; 136 Deng (B10) 2020; 148 Yu (B91) 2021; 180 Tang (B72) 2019; 572 Liu (B34) 2021 Yang (B88) 2020; 445 Yu (B92) 2019; 110 Yamane (B85) 2021 Zou (B108) 2017; 130 Jia (B20) 2021; 908 Reliene (B53) 2006; 27 Wang (B76) 2021; 12 Magusto (B38) 2020; 214 Ramos-Tovar (B52) 2020; 9 Dixon (B11) 2012; 149 Ota (B47) 2021; 1261 Li (B28) 2020; 40 Qi (B50) 2020; 190 Stockwell (B63) 2017; 171 Kong (B24) 2019; 109 Yin (B89) 2014; 146 Gao (B14) 2021; 75 Zhang (B97) 2020; 235 Guo (B16) 2018; 50 Zhou (B104) 2019; 3 Shang (B59) 2020; 72 Gao (B15) 2017; 12 Kuo (B26) 2020; 144 Bai (B3) 2020; 235 Sun (B67); 64 Tsurusaki (B74) 2019; 10 Suzuki (B70) 2002; 26 Shan (B58) 2020; 319 Wang (B78) 2016; 8 Wang (B77) 2021; 200 Nishizawa (B46) 2018; 15 Liu (B32) 2021; 28 Sucher (B65) 2019; 2019 Liu (B33) 2020; 445 Louandre (B36) 2015; 356 Xu (B83) 2021; 573 Zhu (B107) 2017; 38 Capelletti (B6) 2020; 21 Zhao (B102) 2020 Hsieh (B17) 2021; 11 Yan (B86) 2021; 6 Sahebjam (B55) 2015; 9 Zeng (B95) 2020; 152 Miyata (B43) 2020; 26 Liu (B31) 2020; 84 Miotto (B42) 2020; 28 Tang (B71) 2021; 31 Zheng (B103) 2021; 12 Tang (B73) 2021; 548 Martin (B40) 2013; 110 Mehta (B41) 2019; 25 Mao (B39) 2020; 11 Wegrzyniak (B79) 2021; 22 Smid (B62) 2020; 66 Jenkins (B18) 2021; 10 Cui (B9) 2021; 93 Sun (B69) 2020; 133 Cao (B5) 2016; 73 Jiang (B21) 2021; 22 Stockwell (B64) 2020; 30 Fu (B13) 2020 Rouault (B54) 2003; 30 Krümmel (B25) 2021; 1867 Yuan (B94) 2016; 478 Lu (B37) 2021; 9 Sui (B66) 2018; 106 Albano (B1) 2015; 2015 Ou (B48) 2016; 113 Sun (B68); 63 Videla (B75) 2021 Kim (B22) 2020; 43 Lachaier (B27) 2014; 34 Zhou (B105) 2020; 190 Zhang (B98) 2018; 20 Qi (B51) 2019; 9 Llovet (B35) 2021; 7 Sakai (B56) 2017; 24 Zhang (B101) 2018; 14 Ndiaye (B44) 2020; 40 Zhang (B100); 36 Zhu (B106) 2020; 2020 Yang (B87) 2014; 156 Xie (B81) 2016; 473 Shojaie (B61) 2020; 21 Li (B29) 2020; 160 Li (B30) 2021; 36 Bai (B2) 2019; 23 Komissarov (B23) 2021; 22 Xiong (B82) 2021; 332 Chen (B8) 2020; 10 Nie (B45) 2018; 144 Wu (B80) 2021; 7 Shen (B60) 2021; 47 Chen (B7) 2021; 26 Bai (B4) 2017; 491 Xu (B84) 2018; 43 Jenkitkasemwong (B19) 2015; 22 |
References_xml | – volume: 144 start-page: 172 year: 2020 ident: B26 article-title: Chrysophanol Attenuates Hepatitis B Virus X Protein-Induced Hepatic Stellate Cell Fibrosis by Regulating Endoplasmic Reticulum Stress and Ferroptosis publication-title: J. Pharmacol. Sci. doi: 10.1016/j.jphs.2020.07.014 – volume: 9 start-page: 661 year: 2021 ident: B37 article-title: ENO3 Promoted the Progression of NASH by Negatively Regulating Ferroptosis via Elevation of GPX4 Expression and Lipid Accumulation publication-title: Ann. Transl. Med. doi: 10.21037/atm-21-471 – volume: 15 start-page: 8735 year: 2018 ident: B46 article-title: Low Tumor Glutathione Level as a Sensitivity Marker for Glutamate-Cysteine Ligase Inhibitors publication-title: Oncol. Lett. doi: 10.3892/ol.2018.8447 – volume: 93 start-page: 312 year: 2021 ident: B9 article-title: ACSL4 Exacerbates Ischemic Stroke by Promoting Ferroptosis-Induced Brain Injury and Neuroinflammation publication-title: Brain Behav. Immun. doi: 10.1016/j.bbi.2021.01.003 – volume: 13 start-page: 91 year: 2017 ident: B12 article-title: ACSL4 Dictates Ferroptosis Sensitivity by Shaping Cellular Lipid Composition publication-title: Nat. Chem. Biol. doi: 10.1038/nchembio.2239 – volume: 40 start-page: 1378 year: 2020 ident: B28 article-title: Targeting Ferroptosis Alleviates Methionine‐Choline Deficient (MCD)‐Diet Induced NASH by Suppressing Liver Lipotoxicity publication-title: Liver Int. doi: 10.1111/liv.14428 – volume: 23 start-page: 7349 year: 2019 ident: B2 article-title: Sigma‐1 Receptor Protects Against Ferroptosis in Hepatocellular Carcinoma Cells publication-title: J. Cell Mol. Med. doi: 10.1111/jcmm.14594 – volume: 160 start-page: 845 year: 2020 ident: B29 article-title: Iron Regulatory Protein 2 Is Required for Artemether-Mediated Anti-Hepatic Fibrosis Through Ferroptosis Pathway publication-title: Free Radic. Biol. Med. doi: 10.1016/j.freeradbiomed.2020.09.008 – volume: 9 start-page: 187 year: 2015 ident: B55 article-title: Autoimmune Hepatitis publication-title: Front. Med. doi: 10.1007/s11684-015-0386-y – volume: 12 start-page: e0170350 year: 2017 ident: B15 article-title: Synergistic Interaction of Light Alcohol Administration in the Presence of Mild Iron Overload in a Mouse Model of Liver Injury: Involvement of Triosephosphate Isomerase Nitration and Inactivation publication-title: PLoS One doi: 10.1371/journal.pone.0170350 – volume: 908 start-page: 174319 year: 2021 ident: B20 article-title: Ferroptosis as a New Therapeutic Opportunity for Nonviral Liver Disease publication-title: Eur. J. Pharmacol. doi: 10.1016/j.ejphar.2021.174319 – volume: 548 start-page: 27 year: 2021 ident: B73 article-title: Ferrostatin-1 Attenuates Ferroptosis and Protects the Retina Against Light-Induced Retinal Degeneration publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2021.02.055 – volume: 149 start-page: 1060 year: 2012 ident: B11 article-title: Ferroptosis: an Iron-Dependent Form of Nonapoptotic Cell Death publication-title: Cell doi: 10.1016/j.cell.2012.03.042 – volume: 27 start-page: 240 year: 2006 ident: B53 article-title: Glutathione Depletion by Buthionine Sulfoximine Induces DNA Deletions in Mice publication-title: Carcinogenesis doi: 10.1093/carcin/bgi222 – volume: 332 start-page: 539 year: 2021 ident: B82 article-title: Self-Assembled Nano-Activator Constructed Ferroptosis-Immunotherapy Through Hijacking Endogenous Iron to Intracellular Positive Feedback Loop publication-title: J. Control. Release doi: 10.1016/j.jconrel.2021.03.007 – volume: 190 start-page: 68 year: 2020 ident: B50 article-title: Ferroptosis Affects the Progression of Nonalcoholic Steatohepatitis via the Modulation of Lipid Peroxidation-Mediated Cell Death in Mice publication-title: Am. J. Pathol. doi: 10.1016/j.ajpath.2019.09.011 – volume: 30 start-page: 103 year: 2003 ident: B54 article-title: Hepatic Iron Overload in Alcoholic Liver Disease: Why Does it Occur and What Is Its Role in Pathogenesis? publication-title: Alcohol doi: 10.1016/s0741-8329(03)00102-2 – volume: 3 start-page: 656 year: 2019 ident: B104 article-title: Adipose‐Specific Lipin‐1 Overexpression Renders Hepatic Ferroptosis and Exacerbates Alcoholic Steatohepatitis in Mice publication-title: Hepatol. Commun. doi: 10.1002/hep4.1333 – volume: 28 start-page: 101328 year: 2020 ident: B42 article-title: Insight Into the Mechanism of Ferroptosis Inhibition by Ferrostatin-1 publication-title: Redox Biol. doi: 10.1016/j.redox.2019.101328 – start-page: 1703 year: 2020 ident: B13 article-title: Artemether Regulates Metaflammation to Improve Glycolipid Metabolism in db/db Mice publication-title: Diabetes Metab. Syndr. Obes. doi: 10.2147/DMSO.S240786 – volume: 10 start-page: 21184 year: 2020 ident: B8 article-title: Response to Iron Overload in Cultured Hepatocytes publication-title: Sci. Rep. doi: 10.1038/s41598-020-78026-6 – volume: 478 start-page: 838 year: 2016 ident: B94 article-title: CISD1 Inhibits Ferroptosis by Protection Against Mitochondrial Lipid Peroxidation publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2016.08.034 – volume: 1867 start-page: 166114 year: 2021 ident: B25 article-title: The Central Role of Glutathione Peroxidase 4 in the Regulation of Ferroptosis and Its Implications for Pro-Inflammatory Cytokine-Mediated Beta-Cell Death publication-title: Biochim. Biophys. Acta Mol. Basis Dis. doi: 10.1016/j.bbadis.2021.166114 – volume: 22 start-page: 7348 year: 2021 ident: B79 article-title: Recent Progress in the Molecular Imaging of Nonalcoholic Fatty Liver Disease publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms22147348 – volume: 11 start-page: 518 year: 2020 ident: B39 article-title: The Emerging Role of Ferroptosis in Non-Cancer Liver Diseases: Hype or Increasing Hope? publication-title: Cell Death Dis. doi: 10.1038/s41419-020-2732-5 – volume: 12 start-page: 447 year: 2021 ident: B76 article-title: Mitochondrial Ferritin Attenuates Cerebral Ischaemia/reperfusion Injury by Inhibiting Ferroptosis publication-title: Cell Death Dis. doi: 10.1038/s41419-021-03725-5 – volume: 34 start-page: 6417 year: 2014 ident: B27 article-title: Sorafenib Induces Ferroptosis in Human Cancer Cell Lines Originating From Different Solid Tumors publication-title: Anticancer Res. – volume: 109 start-page: 2043 year: 2019 ident: B24 article-title: Artesunate Alleviates Liver Fibrosis by Regulating Ferroptosis Signaling Pathway publication-title: Biomed. Pharmacother. doi: 10.1016/j.biopha.2018.11.030 – volume: 235 start-page: 5637 year: 2020 ident: B3 article-title: MicroRNA‐214‐3p Enhances Erastin‐Induced Ferroptosis by Targeting ATF4 in Hepatoma Cells publication-title: J. Cell Physiol. doi: 10.1002/jcp.29496 – volume: 491 start-page: 919 year: 2017 ident: B4 article-title: Haloperidol, a Sigma Receptor 1 Antagonist, Promotes Ferroptosis in Hepatocellular Carcinoma Cells publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2017.07.136 – volume: 235 start-page: 3425 year: 2020 ident: B97 article-title: Inhibition of Tumor Propellant Glutathione Peroxidase 4 Induces Ferroptosis in Cancer Cells and Enhances Anticancer Effect of Cisplatin publication-title: J. Cell Physiol. doi: 10.1002/jcp.29232 – volume: 319 start-page: 322 year: 2020 ident: B58 article-title: Ferroptosis-Driven Nanotherapeutics for Cancer Treatment publication-title: J. Control. Release doi: 10.1016/j.jconrel.2020.01.008 – volume: 8 start-page: 308 year: 2016 ident: B78 article-title: The Protective Role of Mitochondrial Ferritin on Erastin-Induced Ferroptosis publication-title: Front. Aging Neurosci. doi: 10.3389/fnagi.2016.00308 – volume: 6 start-page: 49 year: 2021 ident: B86 article-title: Ferroptosis: Mechanisms and Links With Diseases publication-title: Sig. Transduct. Target. Ther. doi: 10.1038/s41392-020-00428-9 – volume: 21 start-page: 4908 year: 2020 ident: B6 article-title: Ferroptosis in Liver Diseases: An Overview publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms21144908 – volume: 2015 start-page: 1 year: 2015 ident: B1 article-title: Regulation of Systemxc-By Pharmacological Manipulation of Cellular Thiols publication-title: Oxid. Med. Cell Longev. doi: 10.1155/2015/269371 – volume: 40 year: 2020 ident: B44 article-title: Immunohistochemical Staining Reveals Differential Expression of ACSL3 and ACSL4 in Hepatocellular Carcinoma and Hepatic Gastrointestinal Metastases publication-title: Biosci. Rep. doi: 10.1042/BSR20200219 – volume: 20 start-page: 1181 year: 2018 ident: B98 article-title: BAP1 Links Metabolic Regulation of Ferroptosis to Tumour Suppression publication-title: Nat. Cell Biol doi: 10.1038/s41556-018-0178-0 – volume: 136 start-page: 726 year: 2020 ident: B93 article-title: Aug 6)Hepatic Transferrin Plays a Role in Systemic Iron Homeostasis and Liver Ferroptosis publication-title: Blood doi: 10.1182/blood.2019002907 – volume: 24 start-page: 101211 year: 2019 ident: B96 article-title: Ferroptosis Is Governed by Differential Regulation of Transcription in Liver Cancer publication-title: Redox Biol. doi: 10.1016/j.redox.2019.101211 – volume: 14 start-page: 2083 year: 2018 ident: B101 article-title: Activation of Ferritinophagy Is Required for the RNA-Binding Protein ELAVL1/HuR to Regulate Ferroptosis in Hepatic Stellate Cells publication-title: Autophagy doi: 10.1080/15548627.2018.1503146 – year: 2021 ident: B34 article-title: Signaling Pathways and Defense Mechanisms of Ferroptosis publication-title: FEBS J. doi: 10.1111/febs.16059 – volume: 9 start-page: 6209 year: 2019 ident: B57 article-title: Mitochondrial Membrane Anchored Photosensitive Nano-Device for Lipid Hydroperoxides Burst and Inducing Ferroptosis to Surmount Therapy-Resistant Cancer publication-title: Theranostics doi: 10.7150/thno.36283 – volume: 190 start-page: 82 year: 2020 ident: B105 article-title: Intestinal SIRT1 Deficiency Protects Mice From Ethanol-Induced Liver Injury by Mitigating Ferroptosis publication-title: Am. J. Pathol. doi: 10.1016/j.ajpath.2019.09.012 – volume: 25 start-page: 521 year: 2019 ident: B41 article-title: Iron and Liver Fibrosis: Mechanistic and Clinical Aspects publication-title: World J. Gastroenterol. doi: 10.3748/wjg.v25.i5.521 – volume: 573 start-page: 48 year: 2021 ident: B83 article-title: Ferrostatin-1 Alleviated TNBS Induced Colitis via the Inhibition of Ferroptosis publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2021.08.018 – volume: 21 start-page: 9682 year: 2020 ident: B61 article-title: Cell Death in Liver Diseases: A Review publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms21249682 – volume: 200 start-page: 298 year: 2021 ident: B77 article-title: Mitochondrial Ferritin Deficiency Promotes Osteoblastic Ferroptosis via Mitophagy in Type 2 Diabetic Osteoporosis publication-title: Biol. Trace Elem. Res. doi: 10.1007/s12011-021-02627-z – volume: 64 start-page: 488 ident: B67 article-title: Metallothionein-1G Facilitates Sorafenib Resistance Through Inhibition of Ferroptosis publication-title: Hepatology doi: 10.1002/hep.28574 – volume: 2019 start-page: 1 year: 2019 ident: B65 article-title: Autoimmune Hepatitis-Immunologically Triggered Liver Pathogenesis-Diagnostic and Therapeutic Strategies publication-title: J. Immunol. Res. doi: 10.1155/2019/9437043 – volume: 2020 start-page: 1 year: 2020 ident: B106 article-title: The Molecular Mechanisms of Regulating Oxidative Stress-Induced Ferroptosis and Therapeutic Strategy in Tumors publication-title: Oxid. Med. Cell Longe. doi: 10.1155/2020/8810785 – year: 2021 ident: B75 article-title: Perspectives in Liver Redox Imbalance: Toxicological and Pharmacological Aspects Underlying Iron Overloading, Nonalcoholic Fatty Liver Disease, and Thyroid Hormone Action publication-title: Biofactors doi: 10.1002/biof.1797 – volume: 66 start-page: 61 year: 2020 ident: B62 article-title: Liver Fibrosis publication-title: Vnitr Lek doi: 10.36290/vnl.2020.078 – volume: 10 start-page: 449 year: 2019 ident: B74 article-title: Hepatic Ferroptosis Plays an Important Role as the Trigger for Initiating Inflammation in Nonalcoholic Steatohepatitis publication-title: Cell Death Dis. doi: 10.1038/s41419-019-1678-y – volume: 26 start-page: 618 year: 2020 ident: B43 article-title: Programmed Cell Death in Alcohol-Associated Liver Disease publication-title: Clin. Mol. Hepatol. doi: 10.3350/cmh.2020.0142 – volume: 22 start-page: 138 year: 2015 ident: B19 article-title: SLC39A14 Is Required for the Development of Hepatocellular Iron Overload in Murine Models of Hereditary Hemochromatosis publication-title: Cell Metab. doi: 10.1016/j.cmet.2015.05.002 – volume: 133 start-page: 1696 year: 2020 ident: B69 article-title: Regression of Liver Fibrosis: Evidence and Challenges publication-title: Chin. Med. J. (Engl) doi: 10.1097/CM9.0000000000000835 – volume: 180 start-page: 149 year: 2021 ident: B91 article-title: Research Mechanisms of and Pharmaceutical Treatments for Ferroptosis in Liver Diseases publication-title: Biochimie doi: 10.1016/j.biochi.2020.11.002 – volume: 38 start-page: 614 year: 2017 ident: B107 article-title: New Knowledge of the Mechanisms of Sorafenib Resistance in Liver Cancer publication-title: Acta Pharmacol. Sin. doi: 10.1038/aps.2017.5 – volume: 36 start-page: 101619 ident: B100 article-title: The BRD7-P53-Slc25a28 Axis Regulates Ferroptosis in Hepatic Stellate Cells publication-title: Redox Biol. doi: 10.1016/j.redox.2020.101619 – volume: 148 start-page: 151 year: 2020 ident: B10 article-title: Caveolin-1 Dictates Ferroptosis in the Execution of Acute Immune-Mediated Hepatic Damage by Attenuating Nitrogen Stress publication-title: Free Radic. Biol. Med. doi: 10.1016/j.freeradbiomed.2019.12.026 – volume: 84 start-page: 1621 year: 2020 ident: B31 article-title: Ferroptosis Is Involved in Alcohol-Induced Cell Death In Vivo and In Vitro publication-title: Biosci. Biotechnol. Biochem. doi: 10.1080/09168451.2020.1763155 – volume: 28 start-page: 67 year: 2021 ident: B32 article-title: HBx Facilitates Ferroptosis in Acute Liver Failure via EZH2 Mediated SLC7A11 Suppression publication-title: J. Biomed. Sci. doi: 10.1186/s12929-021-00762-2 – volume: 42 start-page: 826 year: 2019 ident: B90 article-title: Sulfasalazine-Induced Ferroptosis in Breast Cancer Cells Is Reduced by the Inhibitory Effect of Estrogen Receptor on the Transferrin Receptor publication-title: Oncol. Rep. doi: 10.3892/or.2019.7189 – volume: 110 start-page: 10777 year: 2013 ident: B40 article-title: Identification of Transferrin Receptor 1 as a Hepatitis C Virus Entry Factor publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.1301764110 – volume: 63 start-page: 173 ident: B68 article-title: Activation of the P62-Keap1-NRF2 Pathway Protects Against Ferroptosis in Hepatocellular Carcinoma Cells publication-title: Hepatology doi: 10.1002/hep.28251 – volume: 9 start-page: 16185 year: 2019 ident: B51 article-title: LncRNA GABPB1-AS1 and GABPB1 Regulate Oxidative Stress During Erastin-Induced Ferroptosis in HepG2 Hepatocellular Carcinoma Cells publication-title: Sci. Rep. doi: 10.1038/s41598-019-52837-8 – volume: 73 start-page: 2195 year: 2016 ident: B5 article-title: Mechanisms of Ferroptosis publication-title: Cell. Mol. Life Sci. doi: 10.1007/s00018-016-2194-1 – volume: 50 start-page: 445 year: 2018 ident: B16 article-title: Ferroptosis: A Novel Anti-Tumor Action for Cisplatin publication-title: Cancer Res. Treat. doi: 10.4143/crt.2016.572 – volume: 379 start-page: 114665 year: 2019 ident: B49 article-title: Protective Effect of Sestrin2 Against Iron Overload and Ferroptosis-Induced Liver Injury publication-title: Toxicol. Appl. Pharmacol. doi: 10.1016/j.taap.2019.114665 – volume: 473 start-page: 775 year: 2016 ident: B81 article-title: Identification of Baicalein as a Ferroptosis Inhibitor by Natural Product Library Screening publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2016.03.052 – volume: 26 start-page: 1092 year: 2021 ident: B7 article-title: Comparison of Ferroptosis-Inhibitory Mechanisms Between Ferrostatin-1 and Dietary Stilbenes (Piceatannol and Astringin) publication-title: Molecules doi: 10.3390/molecules26041092 – volume: 22 start-page: 266 year: 2021 ident: B21 article-title: Ferroptosis: Mechanisms, Biology and Role in Disease publication-title: Nat. Rev. Mol. Cell Biol doi: 10.1038/s41580-020-00324-8 – volume: 130 start-page: 866 year: 2017 ident: B108 article-title: Relationship Between Hepatitis C Virus Infection and Iron Overload publication-title: Chin. Med. J. (Engl) doi: 10.4103/0366-6999.202737 – volume: 106 start-page: 125 year: 2018 ident: B66 article-title: Magnesium Isoglycyrrhizinate Ameliorates Liver Fibrosis and Hepatic Stellate Cell Activation by Regulating Ferroptosis Signaling Pathway publication-title: Biomed. Pharmacother. doi: 10.1016/j.biopha.2018.06.060 – volume: 9 start-page: 1279 year: 2020 ident: B52 article-title: Molecular Mechanisms that Link Oxidative Stress, Inflammation, and Fibrosis in the Liver publication-title: Antioxidants doi: 10.3390/antiox9121279 – volume: 171 start-page: 273 year: 2017 ident: B63 article-title: Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease publication-title: Cell doi: 10.1016/j.cell.2017.09.021 – volume: 572 start-page: 118782 year: 2019 ident: B72 article-title: Dual GSH-Exhausting Sorafenib Loaded Manganese-Silica Nanodrugs for Inducing the Ferroptosis of Hepatocellular Carcinoma Cells publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2019.118782 – volume: 26 start-page: 26S year: 2002 ident: B70 article-title: Up-Regulation of Transferrin Receptor Expression in Hepatocytes by Habitual Alcohol Drinking Is Implicated in Hepatic Iron Overload in Alcoholic Liver Disease publication-title: Alcohol. Clin. Exp. Res. doi: 10.1097/01.ALC.0000026830.27338.23 – volume: 75 start-page: 540 year: 2021 ident: B14 article-title: Dehydroabietic Acid Improves Nonalcoholic Fatty Liver Disease Through Activating the Keap1/Nrf2-ARE Signaling Pathway to Reduce Ferroptosis publication-title: J. Nat. Med. doi: 10.1007/s11418-021-01491-4 – volume: 22 start-page: 7906 year: 2021 ident: B23 article-title: Individual Expression of Hepatitis A Virus 3C Protease Induces Ferroptosis in Human Cells In Vitro publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms22157906 – volume: 24 start-page: 9 year: 2017 ident: B56 article-title: Role of GPx4 in Human Vascular Endothelial Cells, and the Compensatory Activity of Brown Rice on GPx4 Ablation Condition publication-title: Pathophysiology doi: 10.1016/j.pathophys.2016.11.002 – start-page: 5429 year: 2020 ident: B102 article-title: The Role of Erastin in Ferroptosis and Its Prospects in Cancer Therapy publication-title: Onco Targets Ther. doi: 10.2147/OTT.S254995 – volume: 7 start-page: 6 year: 2021 ident: B35 article-title: Hepatocellular Carcinoma publication-title: Nat. Rev. Dis. Primers doi: 10.1038/s41572-020-00240-3 – volume: 445 start-page: 152599 year: 2020 ident: B88 article-title: Study on the Attenuated Effect of Ginkgolide B on Ferroptosis in High Fat Diet Induced Nonalcoholic Fatty Liver Disease publication-title: Toxicology doi: 10.1016/j.tox.2020.152599 – volume: 11 start-page: 7072 year: 2021 ident: B17 article-title: An Innovative NRF2 Nano-Modulator Induces Lung Cancer Ferroptosis and Elicits an Immunostimulatory Tumor Microenvironment publication-title: Theranostics doi: 10.7150/thno.57803 – volume: 356 start-page: 971 year: 2015 ident: B36 article-title: The Retinoblastoma (Rb) Protein Regulates Ferroptosis Induced by Sorafenib in Human Hepatocellular Carcinoma Cells publication-title: Cancer Lett. doi: 10.1016/j.canlet.2014.11.014 – volume: 7 start-page: 276 year: 2021 ident: B80 article-title: Ferroptosis in Liver Disease: New Insights Into Disease Mechanisms publication-title: Cell Death Discov. doi: 10.1038/s41420-021-00660-4 – volume: 72 start-page: 109633 year: 2020 ident: B59 article-title: Ceruloplasmin Suppresses Ferroptosis by Regulating Iron Homeostasis in Hepatocellular Carcinoma Cells publication-title: Cell Signal. doi: 10.1016/j.cellsig.2020.109633 – volume: 156 start-page: 317 year: 2014 ident: B87 article-title: Regulation of Ferroptotic Cancer Cell Death by GPX4 publication-title: Cell doi: 10.1016/j.cell.2013.12.010 – volume: 31 start-page: 107 year: 2021 ident: B71 article-title: Ferroptosis: Molecular Mechanisms and Health Implications publication-title: Cell Res. doi: 10.1038/s41422-020-00441-1 – volume: 36 start-page: 951 year: 2021 ident: B30 article-title: Erastin Induces Ferroptosis via Ferroportin-Mediated Iron Accumulation in Endometriosis publication-title: Hum. Reprod. doi: 10.1093/humrep/deaa363 – volume: 1261 start-page: 223 year: 2021 ident: B47 article-title: Molecular Mechanisms of Nonalcoholic Fatty Liver Disease (NAFLD)/Nonalcoholic Steatohepatitis (NASH) publication-title: Adv. Exp. Med. Biol. doi: 10.1007/978-981-15-7360-6_20 – volume: 146 start-page: 801 year: 2014 ident: B89 article-title: Deletion of SIRT1 from Hepatocytes in Mice Disrupts Lipin-1 Signaling and Aggravates Alcoholic Fatty Liver publication-title: Gastroenterology doi: 10.1053/j.gastro.2013.11.008 – volume: 43 start-page: 985 year: 2020 ident: B22 article-title: Emerging Roles of Ferroptosis in Liver Pathophysiology publication-title: Arch. Pharm. Res. doi: 10.1007/s12272-020-01273-8 – start-page: 00362 year: 2021 ident: B85 article-title: FADS2-Dependent Fatty Acid Desaturation Dictates Cellular Sensitivity to Ferroptosis and Permissiveness for Hepatitis C Virus Replication publication-title: Cell Chem. Biol. doi: 10.1016/j.chembiol.2021.07.022 – volume: 10 start-page: 1030 year: 2021 ident: B18 article-title: Nrf2 in Cancer, Detoxifying Enzymes and Cell Death Programs publication-title: Antioxidants doi: 10.3390/antiox10071030 – volume: 47 start-page: 102151 year: 2021 ident: B60 article-title: N6-Methyladenosine Modification Regulates Ferroptosis Through Autophagy Signaling Pathway in Hepatic Stellate Cells publication-title: Redox Biol. doi: 10.1016/j.redox.2021.102151 – volume: 445 start-page: 152584 year: 2020 ident: B33 article-title: Oxidative Stress-Dependent Frataxin Inhibition Mediated Alcoholic Hepatocytotoxicity Through Ferroptosis publication-title: Toxicology doi: 10.1016/j.tox.2020.152584 – volume: 113 start-page: E6806 year: 2016 ident: B48 article-title: Activation of SAT1 Engages Polyamine Metabolism With P53-Mediated Ferroptotic Responses publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.1607152113 – volume: 16 start-page: 1482 ident: B99 article-title: RNA-Binding Protein ZFP36/TTP Protects Against Ferroptosis by Regulating Autophagy Signaling Pathway in Hepatic Stellate Cells publication-title: Autophagy doi: 10.1080/15548627.2019.1687985 – volume: 30 start-page: 478 year: 2020 ident: B64 article-title: Emerging Mechanisms and Disease Relevance of Ferroptosis publication-title: Trends Cell Biol. doi: 10.1016/j.tcb.2020.02.009 – volume: 152 start-page: 668 year: 2020 ident: B95 article-title: Indoleamine 2, 3-Dioxygenase 1 Enhances Hepatocytes Ferroptosis in Acute Immune Hepatitis Associated With Excess Nitrative Stress publication-title: Free Radic. Biol. Med. doi: 10.1016/j.freeradbiomed.2020.01.009 – volume: 144 start-page: 2329 year: 2018 ident: B45 article-title: Role of Ferroptosis in Hepatocellular Carcinoma publication-title: J. Cancer Res. Clin. Oncol. doi: 10.1007/s00432-018-2740-3 – volume: 43 start-page: 4019 year: 2018 ident: B84 article-title: Ferroptosis Pathway and its Intervention Regulated by Chinese Materia Medica publication-title: Zhongguo Zhong Yao Za Zhi doi: 10.19540/j.cnki.cjcmm.20180517.001 – volume: 214 start-page: 1 year: 2020 ident: B38 article-title: Cell Death Mechanisms in Non-Alcoholic Steatohepatitis publication-title: Biol. Aujourdhui doi: 10.1051/jbio/2020002 – volume: 12 start-page: 698 year: 2021 ident: B103 article-title: Sorafenib Fails to Trigger Ferroptosis Across a Wide Range of Cancer Cell Lines publication-title: Cell Death Dis. doi: 10.1038/s41419-021-03998-w – volume: 110 start-page: 3173 year: 2019 ident: B92 article-title: Targeted Exosome‐encapsulated Erastin Induced Ferroptosis in Triple Negative Breast Cancer Cells publication-title: Cancer Sci. doi: 10.1111/cas.14181 |
SSID | ssj0001257583 |
Score | 2.3953004 |
SecondaryResourceType | review_article |
Snippet | Ferroptosis is a newly discovered type of cell death mediated by iron-dependent lipid peroxide. The disturbance of iron metabolism, imbalance of the amino acid... |
SourceID | doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 801365 |
SubjectTerms | Cell and Developmental Biology cell death ferroptosis fibrosis hepatocellular carcinoma liver diseases |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LS8QwEA4iCF7Et_VFBE9CddsmbXL0tYiIB1HwFpJ0ggvSyu568N8706zLrohevDYpCd90yHyT6TeMHUtVSpC-ToNDbiKyIFJXVnVqAYNd7RQJvFC1xX158yRun-XzTKsvqgmL8sARuLNQu9CTjhph5yJ4cCoH4bPgKhlcbTu2jmfeDJmK2RUMQ1QRrzGRhemzQIlw5IN5dqpIp0zOHUSdXv9PQeb3WsmZw6e_ylYmUSM_j7tdYwvQrLOl2EfyY4PlaGxO6SXqOMQf2lfgbeB9GA7bt3E7Goz4oOF3VIHBr-KFzGiTPfWvHy9v0kkzhNSjm4xTG5wDndeVtL6qQTjfc5m2ocxz0BIsxmESkDy5ILQtQfZK6y2gf-KQKpQotthi0zaww3iV5V3mR5QZiBCkqn1BRK-mf3aUzhLW-0LG-IlSODWseDXIGAhM04FpCEwTwUzYyfSVtyiT8dvkC4J7OpEUrrsHaHczsbv5y-4JO_oylkGPoDVsA-37yCAnlBqZVqETth2NN12qEJrkg4qEVXNmndvL_EgzeOlUt5FZYvCpd_9j83tsmfCgsphM7LPF8fAdDjC4GbvD7jv-BNyU-OI priority: 102 providerName: Directory of Open Access Journals |
Title | The Emerging Role of Ferroptosis in Liver Diseases |
URI | https://www.ncbi.nlm.nih.gov/pubmed/34970553 https://www.proquest.com/docview/2615921739 https://pubmed.ncbi.nlm.nih.gov/PMC8713249 https://doaj.org/article/fdbf05b526924fceb82e4c1fb75fbda0 |
Volume | 9 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1La9wwEB7ShEIvpUn6cJsEBXIKOLVlSbYOJfS1hND2ULqwNyHZUrqw2Km9gebfd8b2LtmyFHq0JUv2SMPMNxp_A3AmCyW9LKs4OMQmIg0idiqvYuvR2dWuIIIXyrb4pq6m4nomZzuwKm81CrDbCu2ontS0XVz8_nV_iQr_jhAn2tu3gWLcCPV4elEQBZl8BHtomHLS06-jtz-EXNA36Yk5OdcqVpmYDeec20fZsFQ9of82L_TvZMoH1mnyDJ6ObiV7P-yDfdjx9QE8HgpN3h8Cx93AKP5EJYnY92bhWRPYxLdtc7tsunnH5jX7Qika7NNwYtM9h-nk84-PV_FYLSEuUY-WsQ3Oec2rXNoyr7xwZeJSbYPi3GvpLTpq0iO6ckFoq7xMlC2tRwXGpiIrRPYCduum9q-A5SnvQ0NCpV6EIIuqzAgJVvRTT6HTCJKVZEw5UolTRYuFQUhBwjS9MA0J0wzCjOB8_cjtwKPxr84fSNzrjkSB3d9o2hszapQJlQuJdFQhnQscwhXcizINLpfBVTaJ4HS1WAZVhuawtW_uOoOgUWqEYpmO4OWweOupMqGJXyiLIN9Y1o132Wyp5z97Wm6Enuid6tf_86Vv4AldUX5MKo5gd9ne-WP0cpbupI8OnPQ7-A_ufPlo |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Emerging+Role+of+Ferroptosis+in+Liver+Diseases&rft.jtitle=Frontiers+in+cell+and+developmental+biology&rft.au=Chen%2C+Si&rft.au=Zhu%2C+Jun-yao&rft.au=Zang%2C+Xin&rft.au=Zhai%2C+Yong-zhen&rft.date=2021-12-14&rft.issn=2296-634X&rft.eissn=2296-634X&rft.volume=9&rft_id=info:doi/10.3389%2Ffcell.2021.801365&rft.externalDBID=n%2Fa&rft.externalDocID=10_3389_fcell_2021_801365 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2296-634X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2296-634X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2296-634X&client=summon |